封面
市場調查報告書
商品編碼
1763178

全球 D-二聚體檢測市場

D-dimer Testing

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球 D-二聚體檢測市場規模將達到 20 億美元

全球D-二聚體檢測市場規模預計在2024年為16億美元,預計到2030年將達到20億美元,在2024-2030年的分析期間內,複合年成長率為4.0%。試劑和耗材是本報告分析的細分市場之一,預計其複合年成長率為3.6%,到分析期結束時規模將達到13億美元。分析儀器細分市場在分析期間內的複合年成長率預計為4.8%。

美國市場規模估計為 4.259 億美元,中國市場預計複合年成長率為 3.8%

預計2024年美國D-二聚體檢測市場規模將達4.259億美元。作為世界第二大經濟體,中國市場規模預計到2030年將達到3.179億美元,在2024-2030年的分析期間內,複合年成長率為3.8%。其他值得關注的區域市場包括日本和加拿大,預計在分析期間內,這兩個市場的複合年成長率分別為3.7%和3.4%。在歐洲,預計德國市場的複合年成長率為4.3%。

全球 D-二聚體檢測市場—主要趨勢與促進因素摘要

為什麼 D-二聚體檢測對於現代醫療診斷至關重要?

D-二聚體檢測是診斷凝血功能障礙(例如深層靜脈栓塞症(DVT) 和肺動脈栓塞(PE))的重要工具。此檢測測量 D-二聚體的存在,D-二聚體是血栓溶解時形成的蛋白質片段,可指示體內凝血功能異常。該檢測在急救和臨床環境中發揮關鍵作用,有助於快速有效地排除嚴重。隨著心血管疾病和靜脈血栓栓塞症(VTE) 盛行率的上升,D-二聚體檢測在醫療保健領域的重要性日益凸顯,有助於確保及時介入並改善患者預後。隨著對高效能精準診斷解決方案的需求不斷成長,D-二聚體檢測在世界各地醫院、診斷中心和實驗室中的應用正在不斷擴大。

技術創新如何改善 D-二聚體檢測?

技術進步正在改變D-二聚體檢測市場,提高診斷過程的準確性、速度和便利性。即時診斷 (POC) 設備的創新使得在急救現場快速進行D-二聚體分析成為可能,幾分鐘內即可提供結果,從而加快臨床決策。此外,自動化、高靈敏度的測量系統也得到了開發,以提高D-二聚體測量的準確性並最大限度地減少假陽性。將D-二聚體檢測整合到結合多種生物標記的多重檢測平台中,進一步提高了診斷能力,尤其是在檢測和管理COVID-19相關凝血障礙等複雜病症方面。這些技術創新不僅提高了D-二聚體檢測的有效性,也擴大了其在各種醫療保健環境中的應用,從而促進了市場成長。

哪些趨勢推動醫療機構採用 D-二聚體檢測?

人們對早期診斷和預防醫學日益成長的興趣推動了醫療機構採用 D-二聚體檢測。由於心血管疾病仍然是全球最大的死亡原因,醫療保健提供者擴大將 D-二聚體檢測作為篩檢血栓性疾病的快速可靠方法。對 POC 診斷解決方案的需求也在推動市場成長,因為這些測試使醫療保健專業人員能夠在急診室、加護病房和偏遠地區進行評估。此外,COVID-19 大流行的持續影響凸顯了血液凝固檢驗的重要性,導致對 D-二聚體檢測的需求激增,以監測和管理與病毒相關的凝血障礙。隨著醫療保健系統優先加強診斷能力,預計這一趨勢將持續下去。

哪些因素推動了 D-二聚體檢測市場的成長?

D-二聚體檢測市場的成長受到多種因素的推動,包括心血管疾病和血栓性疾病盛行率的上升、POC 檢測技術的進步以及急救護理環境中對快速診斷的日益成長的需求。全球高血栓風險的慢性疾病(如糖尿病和肥胖症)的增多,進一步推動了對 D-二聚體檢測的需求。自動化和高靈敏度檢測等技術改進提高了檢測的準確性和效率,鼓勵醫療機構將這些系統納入其診斷方案。此外,COVID-19 大流行提升了血液凝固檢驗的重要性,刺激了 D-二聚體診斷解決方案的投資。這些綜合因素正在推動 D-二聚體檢測市場在醫院、實驗室和 POC 領域繼續擴張。

部分

產品類型(試劑和耗材、分析設備);檢測類型(臨床實驗室檢測、POC 檢測);應用(深層靜脈栓塞症(DVT)、肺動脈栓塞(PE)、瀰漫性血管內凝血 (DIC)、其他);最終用途(醫院、診斷中心、學術和研究機構、其他最終用途)

受訪公司範例

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio/Data Corporation
  • Corgenix
  • F. Hoffmann-La Roche AG
  • Helena Biosciences Europe
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM,而是建立了一個從世界各地的專家收集的內容庫,其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況(成品和原始OEM)預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手,包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP16307

Global D-dimer Testing Market to Reach US$2.0 Billion by 2030

The global market for D-dimer Testing estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$425.9 Million While China is Forecast to Grow at 3.8% CAGR

The D-dimer Testing market in the U.S. is estimated at US$425.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$317.9 Million by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global D-dimer Testing Market - Key Trends & Drivers Summarized

Why Is D-dimer Testing Crucial for Modern Healthcare Diagnostics?

D-dimer testing is an essential diagnostic tool used to detect blood clotting disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This test measures the presence of D-dimer, a protein fragment that forms when a blood clot dissolves, indicating abnormal clotting activity within the body. It plays a critical role in the emergency and clinical settings, as it helps rule out serious conditions quickly and effectively. Given the rising incidence of cardiovascular diseases and venous thromboembolism (VTE), D-dimer testing has become increasingly vital in healthcare, ensuring timely intervention and improved patient outcomes. As the demand for efficient and accurate diagnostic solutions grows, the use of D-dimer tests is expanding across hospitals, diagnostic centers, and laboratories worldwide.

How Are Technological Innovations Enhancing D-dimer Testing?

Technological advancements are transforming the D-dimer testing market, improving the accuracy, speed, and convenience of diagnostic processes. Innovations in point-of-care (POC) testing devices now allow for rapid D-dimer analysis in emergency settings, providing results in minutes and enabling quicker clinical decisions. Automated and high-sensitivity assay systems have also been developed, enhancing the precision of D-dimer measurements and minimizing false positives. Integration of D-dimer testing into multiplex testing platforms that combine multiple biomarkers is further enhancing diagnostic capabilities, particularly for detecting and managing complex conditions like COVID-19-related coagulopathies. These innovations are not only increasing the effectiveness of D-dimer testing but are also expanding its adoption across various healthcare settings, contributing to market growth.

What Trends Are Driving the Adoption of D-dimer Testing in Healthcare Facilities?

The increased focus on early diagnosis and preventive care is driving the adoption of D-dimer testing in healthcare facilities. With cardiovascular diseases remaining a leading cause of mortality globally, healthcare providers are increasingly utilizing D-dimer tests as a quick and reliable method to screen for thrombotic disorders. The demand for POC diagnostic solutions is also boosting market growth, as these tests enable healthcare professionals to conduct assessments in emergency rooms, intensive care units, and remote locations. Furthermore, the ongoing impact of the COVID-19 pandemic has highlighted the importance of coagulation testing, leading to a surge in demand for D-dimer tests to monitor and manage coagulopathies associated with the virus. This trend is expected to continue as healthcare systems prioritize enhanced diagnostic capabilities.

What Factors Are Driving Growth in the D-dimer Testing Market?

The growth in the D-dimer testing market is driven by several factors, including the rising prevalence of cardiovascular and thrombotic diseases, advancements in POC testing technology, and the expanding need for quick diagnostics in emergency care settings. The global increase in chronic conditions such as diabetes and obesity, which are associated with higher risks of blood clots, is further boosting the demand for D-dimer tests. Technological improvements, such as automated and high-sensitivity assays, are enhancing test accuracy and efficiency, encouraging healthcare facilities to integrate these systems into their diagnostic protocols. Additionally, the impact of the COVID-19 pandemic has elevated the importance of coagulation testing, driving investments in D-dimer diagnostic solutions. The combination of these factors is fueling the expansion of the D-dimer testing market across hospitals, laboratories, and POC settings.

SCOPE OF STUDY:

The report analyzes the D-dimer Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Consumables, Analyzers); Test Type (Clinical Laboratory Tests, Point-of-Care Tests); Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications); End-Use (Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio/Data Corporation
  • Corgenix
  • F. Hoffmann-La Roche AG
  • Helena Biosciences Europe
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • D-dimer Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular and Venous Thromboembolism (VTE) Cases
    • Increasing Use of D-dimer Testing in Point-of-Care Settings
    • Growth in Demand for High-Sensitivity D-dimer Assays
    • Technological Advancements in Rapid and Automated D-dimer Testing Devices
    • Rising Adoption of D-dimer Testing in Emergency and Clinical Settings
    • Increasing Focus on Preventive Healthcare and Early Diagnosis
    • Expansion of Telemedicine Services Supporting Remote D-dimer Testing
    • Integration of D-dimer Testing in Multiplex and Comprehensive Test Panels
    • Surge in Demand for Home-Based and Self-Monitoring D-dimer Kits
    • Growth of Diagnostic Laboratories and Testing Facilities Offering D-dimer Services
    • Rising Use of D-dimer Testing for COVID-19-Related Coagulopathy Assessment
    • Increasing Collaboration Between Diagnostic Companies and Healthcare Providers
    • Growth of Healthcare Infrastructure in Emerging Markets Expanding D-dimer Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World D-dimer Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for D-dimer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for D-dimer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for D-dimer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinical Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Clinical Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Clinical Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Point-of-Care Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Point-of-Care Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Point-of-Care Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Deep Vein Thrombosis (DVT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Deep Vein Thrombosis (DVT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Deep Vein Thrombosis (DVT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pulmonary Embolism (PE) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pulmonary Embolism (PE) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pulmonary Embolism (PE) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Disseminated Intravascular Coagulation (DIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Disseminated Intravascular Coagulation (DIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Disseminated Intravascular Coagulation (DIC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for D-dimer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for D-dimer Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 176: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of World Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of World 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of World 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of World 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION